These results suggest that cardiomyocyte-specific overexpression of GCH1 protects SR Ca2+ handling through p38 MAPK-SR Ca2+ handling proteins and BH4-nNOS-SR Ca2+ handling proteins pathways and attenuates cardiac remodeling and dysfunction after MI. The gene discussed is NOS1; the disease is myocardial infarction.